8/24/23 17:58  | 8/24/23  | MYMD | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | GC | P | 167 | 1.11 | 0 | 150 | 60 | 400 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/23 16:21  | 8/17/23  | MYMD | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | GC | P | 28 | 1.12 | 0 | 25 | 11 | 250 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/8/22 20:24  | 12/8/22  | MYMD | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | EVP of O | P | 15 | 1.53 | 0 | 10 | 5 | 225 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/29/21 12:46  | 11/24/21  | MYMD | Health | Diagn | In Vitro & In Vivo Diagnostic | Silverman Joshua | MD | D |  | P.m | 103 | 6.89 | 0 | 15 | 20 | 89 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/24/21 12:56  | 11/23/21  | MYMD | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | EVP of O | P | 90 | 6.03 | 0 | 15 | 8 | 215 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/21/21 17:55  | 4/16/21  | MYMD | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreiber Christopher C | NY | D |  | M.d | 0 | 0.00 | 0 | 132 |  | 88 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/20/21 21:37  | 4/16/21  | MYMD | Health | Diagn | In Vitro & In Vivo Diagnostic | Schroeder Robert C | NY | D |  | M.d | 0 | 0.00 | 0 | 44 |  | 29 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/20/21 21:35  | 4/16/21  | MYMD | Health | Diagn | In Vitro & In Vivo Diagnostic | Silverman Joshua | NY | D |  | M.d | 0 | 0.00 | 0 | 110 |  | 71 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/20/21 21:32  | 4/16/21  | MYMD | Health | Diagn | In Vitro & In Vivo Diagnostic | White Billy Joe | NY | D |  | M.d | 0 | 0.00 | 0 | 110 |  | 71 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/3/20 14:55  | 2/28/20  | AKER | Health | Diagn | In Vitro & In Vivo Diagnostic | Hudson Bay Capital Management LP | NY | T |  | S | -2 | 2.81 | 0 | -1 | 0 | 240 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/27/20 16:06  | 2/25/20  | AKER | Health | Diagn | In Vitro & In Vivo Diagnostic | Hudson Bay Capital Management LP | NY | T |  | S.m | -80 | 2.81 | 0 | -28 | -5 | 497 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/7/20 17:32  | 12/9/19  | AKER | Health | Diagn | In Vitro & In Vivo Diagnostic | Hudson Bay Capital Management LP | NY | T |  | P.m | 556 | 3.01 | 0 | 185 | 98 | 373 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/3/20 19:11  | 1/1/20  | AKER | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreiber Christopher C | NY | DO | Exec CB | M.d | 0 | 0.00 | 0 | 5 | New | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/3/20 19:10  | 1/1/20  | AKER | Health | Diagn | In Vitro & In Vivo Diagnostic | White Billy Joe | NY | D |  | M.d | 0 | 0.00 | 0 | 5 | New | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/3/20 19:07  | 1/1/20  | AKER | Health | Diagn | In Vitro & In Vivo Diagnostic | Silverman Joshua | NY | D |  | M.d | 0 | 0.00 | 0 | 5 | New | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/24/16 17:57  | 5/24/16  | AKER | Health | Diagn | In Vitro & In Vivo Diagnostic | Gormally John J | NJ | O | CEO | P | 6 | 2.23 | 0 | 3 | New | 3 | D | -42 | -45 | 9 | 56 | 28 | 46 | 37 | 27 | -7 | -5 | -6 | 42 | -4 |  | 
1/6/16 06:02  | 1/5/16  | AKER | Health | Diagn | In Vitro & In Vivo Diagnostic | Akers Raymond Francis Jr | NJ | DO | Exec CB, | P | 3 | 1.34 | 0 | 2 | 3 | 72 | I |  | -47 | -51 | -41 | 3 | 46 | 67 | 63 | -6 | -28 | -39 | -18 | 58 | -10 | 
12/14/15 16:16  | 12/11/15  | AKER | Health | Diagn | In Vitro & In Vivo Diagnostic | Rauch Gary M | NJ | O | VP - Fin | P | 5 | 1.50 | 0 | 4 | 233 | 5 | D |  | -54 | -68 | -54 | -50 | -25 | -25 | -4 | -5 | -5 | -9 | 33 | 35 | 26 | 
8/25/14 15:50  | 8/22/14  | AKER | Health | Diagn | In Vitro & In Vivo Diagnostic | Rauch Gary M | NJ | O | VP of Fi | P | 3 | 3.15 | 0 | 1 | 213 | 2 | D |  |  | -34 | -20 | -21 | -8 | -9 | -2 | -6 | -2 | 29 | -17 | 20 | -15 |